期刊文献+

口腔鳞癌组织中IGF-1的表达及其临床意义

Expression and clinical significance of IGF-1 in oral aquamous cell carcinoma
下载PDF
导出
摘要 目的:探讨胰岛素样生长因子1(insulin-like growth factor 1,IGF-1)在口腔鳞状细胞癌(oral squamous cell carcinoma,OSCC)组织中的表达,并分析IGF-1的表达水平与口腔鳞癌患者各临床病理特征及其预后的关系。方法:采用免疫组织化学方法检测80例口腔鳞癌患者癌组织及20例正常口腔黏膜组织中IGF-1的表达。结果:①高、中、低分化口腔鳞癌IGF-1表达阳性率分别为44.1%、53.6%和72.2%(P>0.05);IGF-1表达与口腔鳞癌的病理分级呈正相关(rs=0.245)。②IGF-1表达阳性率在Ⅲ~Ⅳ期组、有颈部淋巴结转移组中分别明显高于Ⅰ~Ⅱ期组、无颈部淋巴结转移组(P<0.05)。③IGF-1阴性表达的口腔鳞癌患者3年生存率(71.4%)明显高于阳性者的(29.0%)(P<0.05)。结论:口腔鳞癌组织中IGF-1表达与肿瘤的分期、分化程度、淋巴结转移及预后有关。 Objective:To investigate the expression of insulin-1ike growth factor 1(IGF-1) in oral squamous cell carcinoma(OSCC) tissues and analyze the clinicopathologic features and outcomes of OSCC on basis of IGF-1 expression.Methods:Immunohistochemical technique was used to detect the expression of IGF-1 in OSCC tissues(n=80) and normal tissues(n=20).Results: ① IGF-1 was positively expressed in cases of well differentiated(44.1%),moderately differentiated(53.6%) and poorly differentiated(72.2%)(P>0.05),and it showed positive correlation with pathological grade of OSCC(r=0.245). ② The expression rate of IGF-1 in stage Ⅲ,Ⅳand cases with positive neck lymph node groups was significantly higher than that of Ⅰ,Ⅱand those with negative neck lymph node(P<0.05).③The 3-year survival in OSCC patients with IGF-1 negative was significantly longer as compared with those with positive IGF-1(71.4% vs 29%,P<0.05).Conclusion:IGF-1 expression level in OSCC tissues is associated with tumor stage and differentiation,involvement of lymph node metastasis and prognosis.
出处 《中国社区医师(医学专业)》 2014年第18期116-118,共3页
关键词 口腔鳞癌 胰岛素样生长因子-1 临床病理特征 Oral squamous cell carcinoma Insulin-1ike growth factor 1 Clinicopathologic feature
  • 相关文献

参考文献6

二级参考文献34

  • 1宋建新,刘秋润.表皮生长因子受体在鼻咽癌及癌前病变组织中的表达[J].临床耳鼻咽喉科杂志,1996,10(6):337-339. 被引量:9
  • 2何杨,吉兆宁,王潞.乳腺癌组织中胰岛素样生长因子结合蛋白-2的表达及其与雌激素受体、孕激素受体相关性的研究[J].中国临床药理学与治疗学,2006,11(8):898-901. 被引量:5
  • 3BASERGA R. The contradictions of the insulin-like growth factor l receptor[J]. Oncogene, 2000, 19: 5574-5581.
  • 4YU H, ROHAN T. Role of the insulin like growth factor family in cancer development and progression [J]. J NatlCancer Inst, 2000, 92:1472-1489.
  • 5LEROITH D, WERNER H, BEITNER-JOHNSON D, et al. Molecular and cellular aspects of the insulinlike growth factor Ⅰ receptor[J]. Endocr Rev, 1995,16: 143-163.
  • 6WERNER H, LEROITH D. New concepts in regulation and function of the insulin like growth factors implications for understanding normal growth and neoplasia[J]. Cell Mol Life Sci,2000,57 : 932-942.
  • 7BASERGA R. The insulin-like growth factor Ⅰ receptor: a key to tumor growth[J]? Cancer Res, 1995, 55:249-252.
  • 8IWAKIRI D, SHEEN T S, CHEN J Y, et al. Epstein-barr virus-encoded small RNA induces insulinlike growth factor 1 and supports growth of nasopharyngeal carcinoma-derived cell lines[J]. Oncogene, 2005, 24:1767-1773.
  • 9CHAN J M, STAMPFER M J, GIOVANNUCCI E, et al. Plasma insulin-like growth factor-Ⅰ and prostate cancer risk: a prospective study[J]. Science, 1998, 279:563-566.
  • 10HANKINSON S E, WILLETT W C, COLDILZ G A, et al. Circulating concentrations of insulin-like growth factor-Ⅰ and risk of breast cancer[J]. Lancet, 1998 ,351:1393-1396.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部